» Articles » PMID: 19074415

The Adhesion Molecule Esam1 is a Novel Hematopoietic Stem Cell Marker

Overview
Journal Stem Cells
Date 2008 Dec 17
PMID 19074415
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Hematopoietic stem cells (HSCs) have been highly enriched using combinations of 12-14 surface markers. Genes specifically expressed by HSCs as compared with other multipotent progenitors may yield new stem cell enrichment markers, as well as elucidate self-renewal and differentiation mechanisms. We previously reported that multiple cell surface molecules are enriched on mouse HSCs compared with more differentiated progeny. Here, we present a definitive expression profile of the cell adhesion molecule endothelial cell-selective adhesion molecule (Esam1) in hematopoietic cells using reverse transcription-quantitative polymerase chain reaction and flow cytometry studies. We found Esam1 to be highly and selectively expressed by HSCs from mouse bone marrow (BM). Esam1 was also a viable positive HSC marker in fetal, young, and aged mice, as well as in mice of several different strains. In addition, we found robust levels of Esam1 transcripts in purified human HSCs. Esam1(-/-) mice do not exhibit severe hematopoietic defects; however, Esam1(-/-) BM has a greater frequency of HSCs and fewer T cells. HSCs from Esam1(-/-) mice give rise to more granulocyte/monocytes in culture and a higher T cell:B cell ratio upon transplantation into congenic mice. These studies identify Esam1 as a novel, widely applicable HSC-selective marker and suggest that Esam1 may play roles in both HSC proliferation and lineage decisions.

Citing Articles

A distinct metabolic and epigenetic state drives trained immunity in HSC-derived macrophages from autoimmune mice.

Mills T, Kain B, Burchill M, Danis E, Lucas E, Culp-Hill R Cell Stem Cell. 2024; 31(11):1630-1649.e8.

PMID: 39413777 PMC: 11560650. DOI: 10.1016/j.stem.2024.09.010.


Pathophysiology in Brain Arteriovenous Malformations: Focus on Endothelial Dysfunctions and Endothelial-to-Mesenchymal Transition.

Jeong J, Bafor A, Freeman B, Chen P, Park E, Kim E Biomedicines. 2024; 12(8).

PMID: 39200259 PMC: 11351371. DOI: 10.3390/biomedicines12081795.


The quest for the holy grail: overcoming challenges in expanding human hematopoietic stem cells for clinical use.

Bastani S, Staal F, Cante-Barrett K Stem Cell Investig. 2023; 10:15.

PMID: 37457748 PMC: 10345135. DOI: 10.21037/sci-2023-016.


Identification and characterization of in vitro expanded hematopoietic stem cells.

Che J, Bode D, Kucinski I, Cull A, Bain F, Becker H EMBO Rep. 2022; 23(10):e55502.

PMID: 35971894 PMC: 9535767. DOI: 10.15252/embr.202255502.


Dntt expression reveals developmental hierarchy and lineage specification of hematopoietic progenitors.

Klein F, Roux J, Cvijetic G, Rodrigues P, von Muenchow L, Lubin R Nat Immunol. 2022; 23(4):505-517.

PMID: 35354960 PMC: 9208307. DOI: 10.1038/s41590-022-01167-5.


References
1.
Calvi L, Adams G, Weibrecht K, Weber J, Olson D, Knight M . Osteoblastic cells regulate the haematopoietic stem cell niche. Nature. 2003; 425(6960):841-6. DOI: 10.1038/nature02040. View

2.
Spangrude G, Heimfeld S, Weissman I . Purification and characterization of mouse hematopoietic stem cells. Science. 1988; 241(4861):58-62. DOI: 10.1126/science.2898810. View

3.
Suzuki N, Ohneda O, Minegishi N, Nishikawa M, Ohta T, Takahashi S . Combinatorial Gata2 and Sca1 expression defines hematopoietic stem cells in the bone marrow niche. Proc Natl Acad Sci U S A. 2006; 103(7):2202-7. PMC: 1413708. DOI: 10.1073/pnas.0508928103. View

4.
Kiel M, Yilmaz O, Iwashita T, Yilmaz O, Terhorst C, Morrison S . SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell. 2005; 121(7):1109-21. DOI: 10.1016/j.cell.2005.05.026. View

5.
Zhang J, Niu C, Ye L, Huang H, He X, Tong W . Identification of the haematopoietic stem cell niche and control of the niche size. Nature. 2003; 425(6960):836-41. DOI: 10.1038/nature02041. View